# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA2051057 | B | Activity of Mycobacterium tuberculosis CYP125A1 assessed as compound oxidation at 50 uM incubated for 1 hr at 25 degC by GC-MS method | Mycobacterium tuberculosis | 13 | ALA2046332 | single protein format | Scientific Literature | |
2. | ALA2051058 | B | Activity of Mycobacterium tuberculosis CYP142A1 assessed as compound oxidation at 50 uM incubated for 1 hr at 25 degC by GC-MS method | Mycobacterium tuberculosis | 13 | ALA2046332 | assay format | Scientific Literature | |
3. | ALA2050172 | B | Activity of Mycobacterium tuberculosis CYP124A1 assessed as compound oxidation at 50 uM incubated for 1 hr at 25 degC by GC-MS method | Mycobacterium tuberculosis | 13 | ALA2046332 | assay format | Scientific Literature | |
4. | ALA4201164 | B | Inhibition of alpha-crystallin B R120G mutant (unknown origin)-induced intracellular protein aggregation expressed in human HeLa cells or HLE-B3 cells at 0.4 uM incubated for 6 to 8 hrs by fluorescence microscopy relative to untreated control | Homo sapiens | 39 | ALA4196177 | cell-based format | Scientific Literature | |
5. | ALA4201165 | B | Inhibition of alpha-crystallin B R120G mutant (unknown origin)-induced intracellular protein aggregation expressed in human HeLa cells or HLE-B3 cells at 4 uM incubated for 6 to 8 hrs by fluorescence microscopy relative to untreated control | Homo sapiens | 39 | ALA4196177 | cell-based format | Scientific Literature |